(firstQuint)Comparison of 3 Versus 6-Month Use of CGMS in Non-Insulin Using T2DM Patients.

 Patients not receiving any insulin treatment with an HbA1c 7.

5% before their scheduled primary care appointment will be invited to participate in the study and wear professional CGM for at least 3 days at either 3 intervals (baseline, 3-month and 6-month) or 2 intervals (baseline and 6-month).

 After removal, the downloaded report will provide quantitative data to determine the percent of time spent in the target range.

 The 6-month data will be analyzed to determine if frequency of professional CGM wear positively affects time spent in target range.

.

 Comparison of 3 Versus 6-Month Use of CGMS in Non-Insulin Using T2DM Patients@highlight

To determine whether 3-month versus 6-month professional CGM utilization improves time spent in target range of 70-140mg/dl in patients with poorly controlled T2DM not treated with insulin.

